Patient costs for prophylaxis and treatment of obstetric and gynecologic surgical infections
- 1 May 1991
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 164 (5) , 1377-1380
- https://doi.org/10.1016/0002-9378(91)91475-c
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimensThe American Journal of Surgery, 1988
- Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infectionsAntimicrobial Agents and Chemotherapy, 1988
- Cefoxitin: Its Role in Treatment and Prophylaxis of Obstetric and Gynecologic InfectionsClinical Infectious Diseases, 1988
- Sulbactam/Ampicillin versus Cefoxitin in the Treatment of Obstetric and Gynaecological InfectionsDrugs, 1986
- Penetration of Ciprofloxacin into Gynecological Tissues following Oral and Intravenous AdministrationChemotherapy, 1986
- Current Problems in Antibiotic Treatment in Obstetrics and GynecologyClinical Infectious Diseases, 1985
- Activities of new quinoline derivatives against genital pathogensAntimicrobial Agents and Chemotherapy, 1985
- Risk Factors for Infection at the Operative Site after Abdominal or Vaginal HysterectomyNew England Journal of Medicine, 1982
- Therapy for Experimental Intraabdominal Sepsis: Comparison of Four Cephalosporins with Clindamycin Plus GentamicinThe Journal of Infectious Diseases, 1977
- ANAEROBIC INFECTIONS OF THE FEMALE GENITAL TRACTObstetrical & Gynecological Survey, 1975